LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

Search

Glaukos Corp

Gesloten

SectorGezondheidszorg

97.33 2.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

93

Max

97.42

Belangrijke statistieken

By Trading Economics

Inkomsten

15M

-18M

Verkoop

1.2M

107M

EPS

-0.22

Winstmarge

-17.012

Werknemers

995

EBITDA

1.6M

-21M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+27.68% upside

Dividenden

By Dow Jones

Volgende Winsten

30 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

122M

5.5B

Vorige openingsprijs

94.79

Vorige sluitingsprijs

97.33

Nieuwssentiment

By Acuity

62%

38%

331 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Glaukos Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mei 2025, 23:48 UTC

Populaire aandelen

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22 mei 2025, 23:07 UTC

Top Nieuws

Fortescue Energy CEO to Resign in Executive Overhaul

22 mei 2025, 23:03 UTC

Belangrijke Marktbewegers

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22 mei 2025, 23:59 UTC

Marktinformatie

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22 mei 2025, 23:45 UTC

Marktinformatie

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22 mei 2025, 23:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mei 2025, 23:23 UTC

Marktinformatie

Global Energy Roundup: Market Talk

22 mei 2025, 23:23 UTC

Marktinformatie

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22 mei 2025, 23:12 UTC

Top Nieuws

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22 mei 2025, 21:54 UTC

Top Nieuws

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22 mei 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2025, 20:46 UTC

Acquisities, Fusies, Overnames

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22 mei 2025, 20:39 UTC

Winsten

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22 mei 2025, 20:36 UTC

Top Nieuws

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22 mei 2025, 20:36 UTC

Top Nieuws
Winsten

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22 mei 2025, 20:32 UTC

Top Nieuws
Winsten

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mei 2025, 20:27 UTC

Top Nieuws

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22 mei 2025, 20:20 UTC

Top Nieuws

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mei 2025, 20:17 UTC

Top Nieuws

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22 mei 2025, 20:16 UTC

Winsten

Intchains Group 1Q Rev $18.2M >ICG

22 mei 2025, 20:15 UTC

Top Nieuws

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mei 2025, 20:08 UTC

Top Nieuws
Winsten

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mei 2025, 20:05 UTC

Top Nieuws

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22 mei 2025, 20:04 UTC

Winsten

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22 mei 2025, 20:04 UTC

Winsten

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22 mei 2025, 20:01 UTC

Winsten

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q Net $68M >WDAY

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q EPS 25c >WDAY

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q Adj EPS $2.23 >WDAY

Peer Vergelijking

Prijswijziging

Glaukos Corp Prognose

Koersdoel

By TipRanks

27.68% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 124.09 USD  27.68%

Hoogste 165 USD

Laagste 86 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Glaukos Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

10

Buy

1

Hold

1

Sell

Technische score

By Trading Central

87.61 / 93Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

331 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.